Avion Wealth’s enVVeno Medical NVNO Stock Holding History

Avion Wealth’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-57	Closed	-$1K	–	1479
2025 Q3	$1K	Hold	57	–	–	﹤0.01%	1066
2025 Q2	$7K	Buy	+57	New	+$6.74K	﹤0.01%	553

Other funds holding NVNO

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Avion Wealth's NVNO Position: Q4 2025 in Review

Avion Wealth sold out of enVVeno Medical (NVNO) in Q4 2025, closing a stake of 57 shares — an estimated $1K sold.

Avion Wealth first reported a position in NVNO in Q2 2025 and held it in 2 quarters. The position peaked at $7K in Q2 2025. 36 funds tracked by Wall St. Rank hold NVNO as of Q4 2025.

Avion Wealth reported no remaining enVVeno Medical position as of Q4 2025 after selling out during the quarter.
Avion Wealth sold 57 enVVeno Medical shares in Q4 2025, an estimated $1K.
Avion Wealth first reported a position in enVVeno Medical in Q2 2025 and held it in 2 quarters.
Avion Wealth's enVVeno Medical position peaked at $7K in Q2 2025.
36 funds tracked by Wall St. Rank held enVVeno Medical as of Q4 2025.

Based on Avion Wealth's 13F filing for Q4 2025, filed 23 Jan 2026.